Blood marker may predict deadly bleeding in Life-Support patients
NCT ID NCT07039513
First seen Dec 08, 2025 · Last updated May 15, 2026 · Updated 19 times
Summary
This study will follow 100 intensive care patients on ECMO, a machine that helps the heart and lungs. The goal is to see if changes in a blood marker called D-dimer can warn doctors about serious bleeding within the next 24 hours. Researchers hope to find a clear threshold to improve patient safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ECMO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service de Médecine Intensive - Réanimation Nouvel Hôpital Civil
Strasbourg, 67098, France
Conditions
Explore the condition pages connected to this study.